• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15922 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2012 National Institute for Health and Care Excellence (NICE) Endovascular stent insertion for intracranial atherosclerotic disease. NICE interventional procedures guidance 429
2012 National Institute for Health and Care Excellence (NICE) Partial replacement of the meniscus of the knee using a biodegradable scaffold. NICE interventional procedures guidance 430
2012 National Institute for Health and Care Excellence (NICE) Percutaneous balloon cryoablation for pulmonary vein isolation in atrial fibrillation. NICE interventional procedures guidance 427
2012 National Institute for Health and Care Excellence (NICE) Focal therapy using cryoablation for localised prostate cancer. NICE interventional procedures guidance 423
2012 National Institute for Health and Care Excellence (NICE) Micropressure therapy for refractory Ménière's disease. NICE interventional procedures guidance 426
2012 National Institute for Health and Care Excellence (NICE) Incisionless otoplasty. NICE interventional procedures guidance 422
2012 National Institute for Health and Care Excellence (NICE) Breast reconstruction using lipomodelling after breast cancer treatment. NICE interventional procedures guidance 417
2012 National Institute for Health and Care Excellence (NICE) PeritX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites. NICE medical technologies guidance 9
2012 National Institute for Health and Care Excellence (NICE) Pipeline Flex embolisation device with Shield Technology for the treatment of complex intracranial aneurysms. NICE medical technologies guidance 10
2012 National Institute for Health and Care Excellence (NICE) Mega Soft Patient Return Electrode for use during monopolar electrosurgery. NICE medical technologies guidance 11
2012 National Institute for Health and Care Excellence (NICE) New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners. NICE diagnostics guidance 3
2012 National Institute for Health and Care Excellence (NICE) Depth of anaesthesia monitors – Bispectral Index (BIS), E-Entropy and Narcotrend-Compact M. NICE diagnostics guidance 6
2012 National Institute for Health and Care Excellence (NICE) SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liver. NICE diagnostics guidance 5
2012 Canary Health Service [Cost-effectiveness of expanded newborn screening by mass spectrometry]
2012 Canary Health Service [Cost-effectiveness of newborn screening for cystic fibrosis]
2012 Canary Health Service [Effectiveness and cost-effectiveness of different pertussis immunization strategies to reduce infant morbidity and mortality]
2012 Canary Health Service [Effectiveness and cost-effectiveness of determining abeta-42, total tau, and phosphorylated tau proteins in cerebrospinal fluid as biomarkers for Alzheimer's disease]
2012 Canary Health Service [Efficacy and cost-effectiveness of cardiac rehabilitation in patients with ischemic heart disease in the outpatient setting (update)]
2012 Canary Health Service [Effectiveness and safety of endovascular procedures in thoracic aortic diseases]
2012 Canary Health Service [Systematic review of the economic impact of MRI-guided surgery (update)]
2012 Canary Health Service [Effectiveness, safety and efficiency of drug-coated stents]
2012 Canary Health Service [Therapeutic management of retinitis pigmentosa]
2012 Canary Health Service [Organisational models in cancer pain management]
2011 NIHR Health Technology Assessment programme A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study)
2011 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Literature review of organisational and patient aspects in HTA]
2011 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Benefit assessment of HPV testing in primary screening for cervical cancer]
2011 NIHR Health Technology Assessment programme Conservative treatment for urinary incontinence in Men After Prostate Surgery (MAPS): two parallel randomised controlled trials
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of monitoring of psychotherapeutic treatments: a randomized comparison on the effects of feedback to therapists and patients in three settings of outpatient psychotherapy]
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [Psychological treatment of personality disorders: a multi-centered randomised controlled trial on the (cost-)effectiveness of schema-focused therapy]
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [Validation of the 'Trimbos and iMTA questionnaire on costs associated with psychiatric illness' (TiC-P) for measuring health care utilisation and production loss]
2011 Health Council of the Netherlands Gezondheidsraad (GR) [Population screening for cervical cancer]
2011 NIHR Health Technology Assessment programme A multicentre randomised controlled trial and economic evaluation of ion-exchange water softeners for the treatment of eczema in children: the Softened Water Eczema Trial (SWET)
2011 Basque Office for Health Technology Assessment (OSTEBA) [Analysis and development of preventive activities in primary care. Review of the preferential offer and its support software (PAP)]
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of nutritional screening and intervention in elderly subjects after hip fracture]
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [The cost-effectiveness of multidisciplinary management of tinnitus at a specialised tinnitus center]
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [Nurse-endoscopy of the colon; a randomized trial on accuracy, patient experiences and costs]
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [A prospective, randomised controlled trial comparing in-hospital treatment and early assisted discharge for exacerbations of chronic obstructive pulmonary disease (COPD)]
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [Quantifying COPD patients preferences for early assisted discharge and inpatient hospital care for COPD exacerbations: a discrete choice experiment]
2011 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Antipsychotic polypharmacy in the treatment of schizophrenia]
2011 NIHR Health Technology Assessment programme EVerT: cryotherapy versus salicylic acid for the treatment of verrucae - a randomised controlled trial
2011 The Swedish Council on Health Technology Assessment (SBU) [Percutaneous vertebroplasty and balloon kyphoplasty in treating painful osteoporotic vertebral compression fractures]
2011 NIHR Health Technology Assessment programme The RATPAC (Randomised Assessment of Treatment using Panel Assay of Cardiac markers) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department
2011 NIHR Health Technology Assessment programme A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-a) inhibitors, adalimumab and infliximab, for Crohn's disease
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [A classification algorithm for low back pain: matching patients to treatments that they are most likely to benefit from]
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [A randomised controlled trial comparing the cost-effectiveness of pelvic floor muscle exercise versus the TVT (O) procedure for female moderate to severe stress urinary incontinence]
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [A randomized clinical trial of urinary incontinence in older women: cost-effectiveness of protocolized assessment and evidence-based treatment]
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [Assessment of Perinatal Outcome after Sustained Tocolysis for Early Labour (APOSTEL II)]
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [Cost effectiveness of a collaborative stepped care intervention for anxiety disorders in the primary care setting]
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [Economic evaluation of joint replacement surgery alongside a multi-centre randomized trial in elderly patients with displaced femoral neck fractures]
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [Effects of a structured progressive task-oriented circuit training program to enhance walking competency after stroke (Acronym: FIT-STROKE Trial)]
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [Group medical appointments for neuromuscular patients]
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [Primary G-CSF prophylaxis during the first two cycles only or throughout all chemotherapy cycles in breast cancer patients at risk of febrile neutropenia]
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [Rivastigmine for delirium in intensive care patients, a double-blind, randomised placebo-controlled add-on trial]
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [Surveillance after polypectomy - towards efficient guidelines]
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [The DExamethasone for Cardiac Surgery (DECS) trial: a large but simple trial to quantify the cost-effectiveness of dexamethasone in patients undergoing cardiac surgery]
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [The effects and costs of cranberry use to prevent clinical urinary tract infections in nursing home residents]
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [The efficacy of 'Radioguided Occult Lesion Localization' (ROLL) versus 'Wire-guided Localization' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomized controlled trial]
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [The long run - short run efficiency paradox in health care]
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [Transmural care for hand eczema; a randomised controlled trial and cost-effectiveness evaluation]
2011 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Clinical practice guideline on borderline personality disorders]
2011 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Informative value of Patient-Reported Outcomes (PRO) in Health Technology Assessment (HTA)]
2011 NIHR Health Technology Assessment programme Processes in recruitment to randomised controlled trials of medicines for children (RECRUIT): a qualitative study
2011 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of management strategies for sciatica: systematic review and economic model
2011 Agency for Healthcare Research and Quality (AHRQ) Transition of care for acute stroke and myocardial infarction patients: from hospitalization to rehabilitation, recovery, and secondary prevention
2011 Medical Advisory Secretariat (MAS) Clinical utility of serologic testing for celiac disease in asymptomatic patients: an evidence-based analysis
2011 NIHR Health Technology Assessment programme An evidence synthesis of qualitative and quantitative research on component intervention techniques, effectiveness, cost-effectiveness, equity and acceptability of different versions of health-related lifestyle advisor role in improving health
2011 NIHR Health Technology Assessment programme Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation
2011 NIHR Health Technology Assessment programme Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor: a systematic review and economic evaluation
2011 NIHR Health Technology Assessment programme VenUS III: a randomised controlled trial of therapeutic ultrasound in the management of venous leg ulcers
2011 NIHR Health Technology Assessment programme Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation
2011 NIHR Health Technology Assessment programme Assessing the surgical skills of trainees in the operating theatre: a prospective observational study of the methodology
2011 NIHR Health Technology Assessment programme Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses
2011 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews, registry database analyses and economic evaluation
2011 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of long-term weight management schemes for adults: a systematic review
2011 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation
2011 NIHR Health Technology Assessment programme Accuracy of bacterial DNA testing for central venous catheter-associated bloodstream infection in children with cancer
2011 NIHR Health Technology Assessment programme Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation
2011 NIHR Health Technology Assessment programme Hysterectomy, endometrial ablation and Mirena for heavy menstrual bleeding: a systematic review of clinical effectiveness and costeffectiveness analysis
2011 NIHR Health Technology Assessment programme The clinical effectiveness and safety of prophylactic retinal interventions to reduce the risk of retinal detachment and subsequent vision loss in adults and children with Stickler syndrome: a systematic review
2011 NIHR Health Technology Assessment programme MAVARIC - a comparison of automation-assisted and manual cervical screening: a randomised controlled trial
2011 NIHR Health Technology Assessment programme Growth monitoring for short stature: update of a systematic review and economic model
2011 NIHR Health Technology Assessment programme Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis
2011 NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day: a systematic review and economic evaluation
2011 NIHR Health Technology Assessment programme Evidence Review Group approaches to the critical appraisal of manufacturer submissions for the NICE STA process: a mapping study and thematic analysis
2011 NIHR Health Technology Assessment programme Development and evaluation by a cluster randomised trial of a psychosocial intervention in children and teenagers experiencing diabetes: the DEPICTED study
2011 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: a systematic review
2011 NIHR Health Technology Assessment programme Evaluating meta-ethnography: systematic analysis and synthesis of qualitative research
2011 NIHR Health Technology Assessment programme Identification of risk factors by systematic review and development of risk-adjusted models for surgical site infection
2011 NIHR Health Technology Assessment programme A randomised controlled trial of post-operative radiotherapy following breast-conserving surgery in a minimum-risk population. Quality of life at 5 years in the PRIME trial
2011 NIHR Health Technology Assessment programme Diagnostic management strategies for adults and children with minor head injury: a systematic review and an economic evaluation
2011 NIHR Health Technology Assessment programme The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation
2011 NIHR Health Technology Assessment programme Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysis
2011 NIHR Health Technology Assessment programme Bone-anchored hearing aids (BAHAs) for people who are bilaterally deaf: a systematic review and economic evaluation
2011 NIHR Health Technology Assessment programme Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys
2011 NIHR Health Technology Assessment programme A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database
2011 NIHR Health Technology Assessment programme Adaptive e-learning to improve dietary behaviour: a systematic review and cost-effectiveness analysis
2011 The Swedish Council on Health Technology Assessment (SBU) [Bleeding peptic ulcer]
2011 The Swedish Council on Health Technology Assessment (SBU) [Benign Prostatic Obstruction (BPO)]
2011 NIHR Health Technology Assessment programme An economic evaluation of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence
2011 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Fibromyalgia and chronic fatigue syndrome: recommendations on diagnosis and treatment]